TRENDS AND CHALLENGES: Access to medicines in Low and Middle-Income Countries

Traditionally it has been believed that the public sector – as the main steward of the health system – is responsible for driving access to medicines. However, COVID-19 pandemic has exposed vast inequities in access to medicines between countries. This has been especially evident for low and middle-income countries.

For the past two decades, the global health community has supported various investments, including public-private partnerships (PPPs), to accelerate access to medicines for LMICs through increasingly sophisticated mechanisms. New public, private and philanthropic resources have served as catalytic funding and these investments have yielded important results. It is important we learn from these various access to medicines initiatives and understand how countries can advance sustainable access to medicines – especially for non-communicable diseases NCDs in the context of Universal Health Coverage UHC.


The two sessions are for professionals working in the field of access to medicines in LMICs both public and private sector. This could include policymakers in Ministries of Health, non-governmental organizations (NGOs), patient organizations, and the private sector (pharmaceutical companies in LMICs or international pharma companies with a focus on LMICs).

Participants must:

– Hold a relevant bachelor’s degree or equivalent

– Have a minimum of 2 years of relevant job experience

– Be proficient in English


Event start 7 September 2022
Event end 14 October 2022